Earnings ·
Perrigo reports Q2 diluted EPS of $0.63, driven by $129.4 million gain from Dermacosmetics sale
PRGOPERRIGO Co plc
Perrigo Company plc reported second quarter 2026 financial results for the period ended June 27, 2026. Reported diluted earnings per share were $0.63, compared to $0.00 in the prior year, driven by a $129.4 million gain on the sale of its Dermacosmetics business. Core net sales declined 3.1% year-over-year to $907 million, while core adjusted diluted EPS fell 20.7% to $0.46. The company reaffirmed its full-year 2026 outlook, projecting adjusted EPS between $2.00 and $2.30 on an All-In basis. Perrigo operates in the consumer self-care and over-the-counter health products industry.